Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as $8.70 and last traded at $8.70, with a volume of 700 shares changing hands. The stock had previously closed at $8.25.
Oxford BioMedica Stock Performance
The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89. The company has a 50 day simple moving average of $7.87 and a two-hundred day simple moving average of $5.91.
About Oxford BioMedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Featured Stories
- Five stocks we like better than Oxford BioMedica
- Bank Stocks – Best Bank Stocks to Invest In
- Sticker Shock: Why Kimberly-Clark’s Sell-Off Is an Overreaction
- How to buy stock: A step-by-step guide for beginners
- Why Hims & Hers Stock May Be a Buy After Mixed Q3 Results
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Why Apple’s Next Quarter Could Be a “Prove It” iPhone 17 Moment
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
